<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17641</article-id><article-id pub-id-type="doi">10.15789/2220-7619-HPC-17641</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Expression of CCR6 on <italic>Helicobacter pylori</italic>-specific circulating CD4+ T cells</article-title><trans-title-group xml:lang="ru"><trans-title>Антигенспецифические Т-лимфоциты в группах CD4+ клеток, различающихся по экспрессии CCR6, у лиц, инфицированных и неинфицированных <italic>Helicobacter pylori</italic></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Talayev</surname><given-names>Vladimir Yu.</given-names></name><name xml:lang="ru"><surname>Талаев</surname><given-names>Владимир Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Professor, Head of the Laboratory of Cellular Immunology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, зав. лабораторией клеточной иммунологии</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zaichenko</surname><given-names>I. Ye.</given-names></name><name xml:lang="ru"><surname>Заиченко</surname><given-names>И. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Leading Researcher, Laboratory of Cellular Immunology</p></bio><bio xml:lang="ru"><p>к.б.н., ведущий научный сотрудник лаборатории клеточной иммунологии</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Svetlova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Светлова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Senior Researcher, Laboratory of Cellular Immunology</p></bio><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник лаборатории клеточной иммунологии</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Voronina</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Воронина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Senior Researcher, Laboratory of Cellular Immunology</p></bio><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник лаборатории клеточной иммунологии</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Babaykina</surname><given-names>O. N.</given-names></name><name xml:lang="ru"><surname>Бабайкина</surname><given-names>О. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Senior Researcher, Laboratory of Cellular Immunology</p></bio><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник лаборатории клеточной иммунологии</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Neumoina</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Неумоина</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Head Physician, Infectious Diseases Clinic</p></bio><bio xml:lang="ru"><p>к.м.н., главный врач Клиники инфекционных болезней</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Perfilova</surname><given-names>K. M.</given-names></name><name xml:lang="ru"><surname>Перфилова</surname><given-names>К. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Deputy Head Physician, Infectious Diseases Clinic</p></bio><bio xml:lang="ru"><p>к.м.н., зам. главного врача Клиники инфекционных болезней</p></bio><email>talaev@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing</institution></aff><aff><institution xml:lang="ru">ФБУН Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. академика И.Н. Блохиной Роспотребнадзора</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-08-14" publication-format="electronic"><day>14</day><month>08</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-25" publication-format="electronic"><day>25</day><month>12</month><year>2024</year></pub-date><volume>14</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>1087</fpage><lpage>1096</lpage><history><date date-type="received" iso-8601-date="2024-04-18"><day>18</day><month>04</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-08-13"><day>13</day><month>08</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Talayev V.Y., Zaichenko I.Y., Svetlova M.V., Voronina E.V., Babaykina O.N., Neumoina N.V., Perfilova K.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Талаев В.Ю., Заиченко И.Е., Светлова М.В., Воронина Е.В., Бабайкина О.Н., Неумоина Н.В., Перфилова К.М.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Talayev V.Y., Zaichenko I.Y., Svetlova M.V., Voronina E.V., Babaykina O.N., Neumoina N.V., Perfilova K.M.</copyright-holder><copyright-holder xml:lang="ru">Талаев В.Ю., Заиченко И.Е., Светлова М.В., Воронина Е.В., Бабайкина О.Н., Неумоина Н.В., Перфилова К.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/17641">https://iimmun.ru/iimm/article/view/17641</self-uri><abstract xml:lang="en"><p><italic>Introduction.</italic> <italic>Helicobacter pylori</italic> can infect human gastric mucosa and cause various pathological conditions. In the blood of <italic>H. pylori</italic>-infected patients, the level of mature CD4<sup>+</sup>CCR6<sup>+</sup> T-lymphocytes, especially pro-inflammatory CCR6<sup>+</sup> T-helper types 1 and 17, significantly increases. Chemokine receptor CCR6 can direct cell migration from the blood into the inflamed gastric mucosa. In this work, we assessed the in vitro response of circulating CD4<sup>+</sup>CCR6<sup>+</sup> and CD4<sup>+</sup>CCR6<sup>–</sup> T cells against <italic>H. pylori</italic> antigens in infected and intact individuals. <italic>Materials and methods.</italic> Monocytes and lymphocytes were isolated from blood samples. Monocytes were incubated with or without <italic>H. pylori</italic>. Monocyte expression of CD14, CD80 and CD86 was assessed, and monocytes were also used to stimulate syngeneic lymphocytes. Antigen-specific lymphocyte response was assessed by proliferation and expression of the activation marker OX40 on CD4<sup>+</sup>CCR6<sup>+</sup> and CD4<sup>+</sup>CCR6<sup>–</sup> T cells. <italic>Results.</italic> Preliminary experiments have shown that incubation of monocytes with <italic>H. pylori</italic> causes a modestly increased expression of the costimulatory molecules CD80 and CD86 on monocytes and a slightly higher level of monocyte potential to stimulate syngeneic lymphocyte proliferation. Evaluation of OX40 expression in an <italic>in vitro</italic> antigen presentation model showed that blood CD4<sup>+</sup> T lymphocytes from infected patients contain cells that are activated by <italic>H. pylori</italic> antigens. In patients with <italic>H. pylori</italic> infection, the CD4<sup>+</sup>CCR6<sup>+</sup> vs CD4<sup>+</sup>CCR6<sup>–</sup> lymphocyte subset contains a larger number of <italic>H. pylori</italic> antigen-specific cells. In the comparison group without <italic>H. pylori infection</italic>, the presentation of <italic>H. pylori</italic> antigens in blood cell cultures did not have a significant effect on the average rates of CD4<sup>+</sup> T-lymphocyte activation. <italic>Conclusion.</italic> The blood of patients with <italic>H. pylori</italic> infection contains CD4<sup>+</sup> T cells that are activated in the presence of <italic>H. pylori</italic> antigens. Blood CD4<sup>+</sup>CCR6<sup>+</sup> vs CD4<sup>+</sup>CCR6<sup>–</sup> T cells from patients with <italic>H. pylori</italic> infection contain a greater number of antigen-specific lymphocytes.</p></abstract><trans-abstract xml:lang="ru"><p><italic>Введение.</italic> <italic>Helicobacter pylori</italic> способен инфицировать слизистую оболочку желудка человека и вызывать различные патологические состояния от бессимптомной инфекции до гастрита, язвенной болезни, аденокарциномы желудка и лимфомы лимфоидной ткани, ассоциированной со слизистой. Предполагается, что форма заболевания зависит от вирулентности возбудителя и ответа организма хозяина, однако роль отдельных групп клеток в иммунном ответе на <italic>H. pylori</italic>-инфекцию до конца не установлена. Ранее было показано, что в крови пациентов, инфицированных <italic>H. pylori</italic>, значительно возрастает содержание зрелых CD4<sup>+</sup>CCR6<sup>+</sup> Т-лимфоцитов, причем в этой группе лимфоцитов увеличивается доля провоспалительных Т-хелперов 1 и 17 типов. Также известно, что хемокиновый рецептор CCR6 может направлять миграцию клеток из крови в воспаленную слизистую оболочку желудка. В этой работе мы оценили <italic>in vitro</italic> ответ циркулирующих CD4<sup>+</sup>CCR6<sup>+</sup> и CD4<sup>+</sup>CCR6<sup>–</sup> Т-клеток на антигены <italic>H. pylori</italic> у инфицированных и неинфицированных лиц. <italic>Материалы и методы.</italic> Из крови обследованных выделяли моноциты и лимфоциты. Моноциты инкубировали с <italic>H. pylori</italic> или без него. Затем оценивали экспрессию СD14, CD80 и CD86 на моноцитах, а также использовали моноциты для стимуляции сингенных лимфоцитов. Реакцию лимфоцитов на антиген оценивали по пролиферации и экспрессии активационного маркера ОХ40 на CD4<sup>+</sup> Т-клетках, различающихся по экспрессии CCR6. <italic>Результаты.</italic> В предварительных экспериментах было показано, что инкубация с <italic>H. pylori</italic> вызывает умеренное усиление экспрессии костимулирующих молекул CD80 и CD86 на моноцитах и небольшое увеличение способности моноцитов стимулировать пролиферацию сингенных лимфоцитов. Оценка экспрессии ОХ40 в модели презентации антигенов <italic>in vitro</italic> показала, что CD4<sup>+</sup> Т-лимфоциты крови инфицированных пациентов содержат выявляемое количество клеток, реагирующих активацией на антигены <italic>H. pylori</italic>. У пациентов с <italic>H. pylori</italic>-инфекцией CD4<sup>+</sup>CCR6<sup>+</sup> субпопуляция лимфоцитов содержит большее количество клеток, специфичных к антигенам возбудителя, по сравнению с CD4<sup>+</sup>CCR6<sup>–</sup> субпопуляцией. У доноров группы сравнения, не имеющих <italic>H. pylori</italic>-инфекции, презентация антигенов возбудителя в культурах клеток крови не оказывала существенного влияния на средние показатели активации CD4<sup>+</sup> Т-лимфоцитов. <italic>Заключение.</italic> Кровь пациентов с <italic>H. pylori</italic>-инфекцией содержит CD4<sup>+</sup> Т-клетки, реагирующие активацией на антигены <italic>H. pylori</italic>. CD4<sup>+</sup>CCR6<sup>+</sup> Т-клетки крови пациентов с <italic>H. pylori</italic>-инфекцией, содержат большее количество антигенспецифических лимфоцитов по сравнению с CD4<sup>+</sup>CCR6<sup>–</sup> Т-клетками.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Helicobacter pylori</kwd><kwd>gastritis</kwd><kwd>T cells</kwd><kwd>immune response</kwd><kwd>activation</kwd><kwd>chemokine receptors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Helicobacter pylori</kwd><kwd>гастрит</kwd><kwd>Т-клетки</kwd><kwd>иммунный ответ</kwd><kwd>активация</kwd><kwd>хемокиновые рецепторы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Талаев В.Ю., Бабайкина О.Н., Светлова М.В. Результаты взаимодействия эпителия желудка с Helicobacter pylori: повреждение клеток, участие эпителиоцитов в иммунном ответе, канцерогенез // Иммунология. 2021. Т. 42, № 5. С. 62–70. [Talayev V.Yu., Babaykina О.N., Svetlova M.V. Results of the interaction of gastric epithelium with Helicobacter pylori: cell damage, participation of epithelial cells in the immune response, carcinogenesis. Immunologiya = Immunologiya, 2021, vol. 42, no. 5, pp. 62–70. (In Russ.)] doi: 10.33029/0206-4952-2021-42-5-0-01</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Талаев В.Ю., Светлова М.В., Заиченко И.Е., Воронина Е.В., Бабайкина О.Н., Неумоина Н.В., Перфилова К.М., Уткин О.В., Филатова Е.Н. Цитокиновый профиль CCR6+ Т-хелперов, выделенных из крови пациентов с язвенной болезнью, ассоциированной с H. pylori-инфекцией // Современные технологии в медицине. 2020. Т. 12, № 3. С. 33–40. [Talayev V.Yu., Svetlova M.V., Zaichenko I.E., Voronina E.V., Babaykina O.N., Neumoina N.V., Perfilova K.M., Utkin O.V., Filatova E.N. Cytokine profile of CCR6+ T-helpers isolated from the blood of patients with peptic ulcer associated with Helicobacter pylori infection. Sovremennye tehnologii v medicine = Modern Technologies in Medicine, 2020, vol. 12, no. 3, pp. 33–40. (In Russ.)] doi: 10.17691/stm2020.12.3.04</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Талаев В.Ю., Талаева М.В., Воронина Е.В., Заиченко И.Е., Неумоина Н.В., Перфилова К.М., Бабайкина О.Н. Экспрессия хемокиновых рецепторов на Т-хелперах крови при заболеваниях, ассоциированных с Helicobacter pylori: хроническом гастродуодените и язвенной болезни // Инфекция и иммунитет. 2019. Т. 9, № 2. С. 295–303. [Talayev V.Yu., Talaeyva M.V., Voronina E.V., Zaichenko I.Ye., Neumoina N.V., Perfilova K.M., Babaykina O.N. Chemokine receptor expression on peripheral blood T-helper cells in Helicobacter pylori-associated diseases: chronic gastroduodenitis and peptic ulcer disease. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2019, vol. 9, no. 2, pp. 295–303. (In Russ.)] doi: 10.15789/2220-7619-2019-2-295-303</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Camilo V., Sugiyama T., Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter, 2017, vol. 22 (suppl. 1): e12405. doi: 10.1111/hel.12405</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chen J.-P., Wu M.-S., Kuo S.-H., Liao F. IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells. PLoS One, 2014, vol. 9: e97350. doi: 10.1371/journal.pone.0097350</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Cheng H.H., Tseng G.Y., Yang H.B., Wang H.J., Lin H.J., Wang W.C. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J. Gastroenterol., 2012, vol. 18, no. 1, pp. 34–43. doi: 10.3748/wjg.v18.i1.34</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cook K.W., Letley D.P., Ingram R.J., Staples E., Skjoldmose H., Atherton J.C., Robinson K. CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa. Gut, 2014, vol. 63, no. 10, pp. 1550–1559. doi: 10.1136/gutjnl-2013-306253</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>D’Elios M.M., Czinn S.J. Immunity, inflammation, and vaccines for Helicobacter pylori. Helicobacter, 2014, vol. 19 (s1), pp. 19–26. doi: 10.1111/hel.12156</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Eaton K.A., Mefford M., Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol., 2001, vol. 166, no. 12, pp. 7456–7461. doi: 10.4049/jimmunol.166.12.7456</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Graham D.Y., Opekun A.R., Osato M.S., El-Zimaity H.M., Lee C.K., Yamaoka Y., Qureshi W.A., Cadoz M., Monath T.P. Challenge model for Helicobacter pylori infection in human volunteers. Gut, 2004, vol. 53, no. 9, pp. 1235–1243. doi: 10.1136/gut.2003.037499</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Gray B.M., Fontaine C.A., Poe S.A., Eaton K.A. Complex T cell interactions contribute to Helicobacter pylori gastritis in mice. Infect. Immun., 2013, vol. 81, no. 3, pp. 740–752. doi: 10.1128/IAI.01269-12</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kao J.Y., Zhang M., Miller M.J., Mills J.C., Wang B., Liu M., Eaton K.A., Zou W., Berndt B.E., Cole T.S., Takeuchi T., Owyang S.Y., Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology, 2010, vol. 138, no. 3, pp. 1046–1054. doi: 10.1053/j.gastro.2009.11.043</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kiriya K., Watanabe N., Nishio A., Okazaki K., Kido M., Saga K., Tanaka J., Akamatsu T., Ohashi S., Asada M., Fukui T., Chiba T. Essential role of Peyer’s patches in the development of Helicobacter-induced gastritis. Int. Immunol., 2007, vol. 19, no. 4, pp. 435–446. doi: 10.1093/intimm/dxm008</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kleinewietfeld M., Puentes F., Borsellino G., Battistini L., Rӧtzschke O., Falk K. CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset. Blood, 2005, vol. 105, no. 7, pp. 2877–2886. doi: 10.1182/blood-2004-07-2505</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Kronsteiner B., Bassaganya-Riera J., Philipson C., Viladomiu M., Carbo A., Abedi V., Hontecillas R. Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes, 2016, vol. 7, pp. 3–21. doi: 10.1080/19490976.2015.1116673</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lina T.T., Alzahrani S., Gonzalez J., Pinchuk I.V., Beswick E.J., Reyes V.E. Immune evasion strategies used by Helicobacter pylori. World J. Gastroenterol., 2014, vol. 20, pp. 12753–12766. doi: 10.3748/wjg.v20.i36.12753</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1984, vol. 1, pp. 1311–1315. doi: 10.1016/s0140-6736(84)91816-6</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Moyat M., Velin D. Immune responses to Helicobacter pylori infection. World J. Gastroenterol., 2014, vol. 20, pp. 5583–5593. doi: 10.3748/wjg.v20.i19.5583</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Müller A., Solnick J.V. Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter, 2011, vol. 16 (s1), pp. 26–32. doi: 10.1111/j.1523-5378.2011.00877.x</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Nurgalieva Z.Z., Conner M.E., Opekun A.R., Zheng C.Q., Elliott S.N., Ernst P.B., Osato M., Estes M.K., Graham D.Y. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect. Immun., 2005, vol. 73, no. 5, pp. 2999–3006. doi: 10.1128/IAI.73.5.2999-3006.2005</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Reiss S., Baxter A.E., Cirelli K.M., Dan J.M., Morou A., Daigneault A., Brassard N., Silvestri G., Routy J.P., Havenar-Daughton C., Crotty S., Kaufmann D.E. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS One, 2017, vol. 12, no. 10: e0186998. doi: 10.1371/journal.pone.0186998</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Roth K., Kapadia S., Martin S., Lorenz R. Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J. Immunol., 1999, vol. 163, no. 3, pp. 1490–1497.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Singh S.P., Zhang H.H., Tsang H., Gardina P.J., Myers T.G., Nagarajan V. Lee C.H., Farber J.M. PLZF regulates CCR6 and is critical for the acquisition and maintenance of the Th17 phenotype in human cells. J. Immunol., 2015, vol. 194, no. 9, pp. 4350–4361. doi: 10.4049/jimmunol.1401093</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Tarke A., Sidney J., Methot N., Yu E.D., Zhang Y., Dan J.M., Goodwin B., Rubiro P., Sutherland A., Wang E., Frazier A., Ramirez S.I., Rawlings S.A., Smith D.M., da Silva Antunes R., Peters B., Scheuermann R.H., Weiskopf D., Crotty S., Grifoni A., Sette A. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell. Rep. Med., 2021, vol. 2, no. 7: 100355. doi: 10.1016/j.xcrm.2021.100355</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wu Y.-Y., Chen J.H., Kao J.T., Liu K.C., Lai C.H., Wang Y.M., Hsieh C.T., Tzen J.T., Hsu P.N. Expression of CD25(high) regulatory T cells and PD-1 in gastric infiltrating CD4(+) T lymphocytes in patients with Helicobacter pylori infection. Clin. Vaccine Immunol., 2011, vol. 18, no. 7, pp. 1198–1201. doi: 10.1128/CVI.00422-10</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wu Y.-Y., Hsieh C.-T., Tsay G.J., Kao J.-T., Chiu Y.-M., Shieh D.-C., Lee Y.-J. Recruitment of CCR6+ Foxp3+ regulatory gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Helicobacter, 2019, vol. 24, no. 1: e12550. doi: 10.1111/hel.12550</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wu Y.-Y., Tsai H.-F., Lin W.-C., Hsu P.-I., Shun C.-T., Wu M.-S., Hsu P.-N. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect. Immun., 2007, vol. 75, no. 9, pp. 4357–4363. doi: 10.1128/IAI.01660-06</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Yoshida A., Isomoto H., Hisatsune J., Nakayama M., Nakashima Y., Matsushima K., Mizuta Y., Hayashi T., Yamaoka Y., Azuma T., Moss J., Hirayama T., Kohno S. Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis. Clin. Immunol., 2009, vol. 130, no. 3, pp. 290–297. doi: 10.1016/j.clim.2008.09.016</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zaunders J.J., Munier M.L., Seddiki N., Pett S., Ip S., Bailey M., Xu Y., Brown K., Dyer W.B., Kim M., de Rose R., Kent S.J., Jiang L., Breit S.N., Emery S., Cunningham A.L., Cooper D.A., Kelleher A.D. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J. Immunol., 2009, vol. 183, no. 4, pp. 2827–2836. doi: 10.4049/jimmunol.0803548</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhang K., Chen L., Zhu C., Zhang M., Liang C. Current knowledge of Th22 cell and IL-22 functions in infectious diseases. Pathogens, 2023, vol. 12, no. 2: 176. doi: 10.3390/pathogens12020176</mixed-citation></ref></ref-list></back></article>
